POET Technologies Doubles Revenue and Sits on $796 Million as Lumilens Order Anchors AI Photonics Ramp

by Karl Lindström · August 18, 2026

Semiconductors & Hardware Reporter, Frontier Tech Wire

POET Technologies Inc. (Nasdaq: POET) reported second-quarter results on August 13 that showed a small-cap photonics supplier still early in commercialization but sharply better capitalized, as the company works to convert design wins in AI data-center optics into production revenue. The results cover the quarter ended June 30, 2026.

Revenue was $569,925, up 112% from $268,469 a year earlier and up 13% sequentially from $503,389 in the first quarter, according to the company's release distributed via GlobeNewswire. POET described the quarter as its sixth consecutive period of sequential revenue growth. The absolute figures remain modest, underscoring that the company's revenue base is still small relative to its ambitions in high-speed optical interconnects.

On a GAAP basis, POET posted a net loss of $11.3 million, or ($0.07) per share, narrowing from a $12.3 million loss in the first quarter and a $17.3 million loss in the second quarter of 2025. The company noted that the quarter's loss included a non-cash gain of $5.5 million tied to derivative warrant liabilities and $4.3 million of other income, alongside $3.8 million of stock-based compensation. Research and development costs rose to $5.8 million from $3.1 million a year earlier, and cash used in operations was $12.2 million.

The balance sheet is the headline change. POET reported $796.3 million in cash and short-term investments at quarter-end, a level that materially reduces the financing risk that has historically shadowed pre-scale photonics names. The cushion followed a $400 million registered direct offering completed in May 2026 at $21 per unit, a premium to the market at the time. The company issued 19,047,620 units, each consisting of one common share and one warrant exercisable at $26.25 through May 18, 2029.

Chairman and Chief Executive Suresh Venkatesan tied the raise directly to execution capacity. "The $400 million strategic investment we completed in the quarter — priced at a premium to market — fundamentally strengthens POET's financial position, removes the uncertainty associated with our staying power and enables management to focus entirely on executing our commercial and operational objectives," he said in the release.

The most concrete commercial signal was a supply relationship with partner Lumilens. POET said Lumilens placed an initial purchase order valued at $50 million for POET Optical Interposer-based engines, and the company stated the arrangement could scale to "$500+ million in cumulative purchases from the Company over five years." That five-year figure is a potential ceiling rather than booked revenue, and it functions as a pipeline indicator rather than committed backlog.

POET's technology centers on its Optical Interposer platform, which integrates lasers and other photonic components at wafer scale to produce optical engines aimed at 800G, 1.6T and higher data rates used in AI clusters and hyperscale data centers. The company also markets its Blazar hybrid laser and, subsequent to quarter-end, said it completed an agreement with what it described as a Tier 1 laser company to develop an external light source engine. POET did not name end customers beyond its partner references.

On execution, Venkatesan framed the period as an inflection. "The second quarter showed POET's transition from development to revenue taking hold: our sixth consecutive quarter of sequential revenue growth, a narrowing net loss, and our optical engine production ramp remaining on schedule for the second half of 2026," he said. The company said it expects to begin shipping substantial production units for qualification over the remaining quarters of 2026.

POET also flagged a leadership addition, appointing Dr. Sandeep Kumar as Chief Operating Officer. Venkatesan said the hire "adds the operational and manufacturing leadership required as we scale our global operations," language that points to the manufacturing-ramp phase the company says it is entering. After quarter-end, POET disclosed a $2.4 million purchase order from an existing customer.

The setup that matters for POET is the gap between demand signals and reported revenue. The Lumilens order and the qualification-shipment timeline suggest volume could inflect in late 2026 and into 2027, but the second quarter's roughly $570,000 of revenue shows how early that curve still is. Gross margin was not disclosed in the release, leaving the profitability path on future volumes unquantified for now.

Management said additional announcements are expected in September, which the company positioned as the next checkpoint on customer qualifications and orders. For a company that spent years as a development-stage story, the combination of a fortified balance sheet, a named multi-year supply framework and a stated production timeline gives the second half of 2026 clearer milestones against which progress can be measured. This article is for informational purposes only and is not investment advice.